Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

If you have questions about filing a Depo-Provera lawsuit, you are not alone. As awareness of the link between Depo-Provera and intracranial meningioma continues to grow, we are continuing to hear ...

Pfizer (NYSE:PFE) is facing an increasing number of lawsuits in the U.S. over its alleged failure to warn that its Depo-Provera contraceptive injection for women can cause a brain tumor called ...

Since the beginning of the year, there has been a rise in the number of lawsuits against pharma giant Pfizer over its injectable contraception, Depo-Provera. Consumers have increasingly joined ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, told lawyers that although there were now 932 lawsuits filed over Depo-Provera, another 9,571 remained ...

New US peer-reviewed study adds to body of research confirming link between use of Depo-Provera and increased risk of brain tumours One of the law firms appointed to the Plaintiff’s Executive ...

While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears to be ...

New US peer-reviewed study adds to body of research confirming link between use of Depo-Provera and increased risk of brain tumours A hearing in the Depo-Provera legal action against Pfizer Inc. (NYSE ...